• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源于横结肠黏液腺癌的腹膜假黏液瘤:1例罕见病例的CT和MRI影像分析

Pseudomyxoma peritonei originating from transverse colon mucinous adenocarcinoma: CT and MRI insights from a rare case.

作者信息

Milillo Paola, Stoppino Luca Pio, Prencipe Gianluca, Piscone Stefano, Saccone Sara, Di Lorenzo Federica, Di Millo Benedetta, Schiraldi Giorgia, Vinci Roberta, Macarini Luca

机构信息

Department of Medical and Surgical Sciences, Section of Diagnostic Imaging, University of Foggia, Foggia, Italy.

Department of Radiology, Unit of Diagnostic and Interventional Radiology, Maggiore Polyclinic Hospital, Foundation IRCCS Ca' Granda, Milan, Italy.

出版信息

Radiol Case Rep. 2025 Jun 26;20(9):4604-4609. doi: 10.1016/j.radcr.2025.06.036. eCollection 2025 Sep.

DOI:10.1016/j.radcr.2025.06.036
PMID:40677872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12268026/
Abstract

Pseudomyxoma peritonei (PMP) is a rare clinical condition, most commonly arising from appendiceal or ovarian mucinous neoplasms. This case report describes an exceptionally rare origin of PMP from a mucinous adenocarcinoma of the transverse colon, highlighting unique diagnostic and therapeutic challenges. Multimodality imaging played a crucial role in the diagnostic process, with computed tomography (CT) providing initial identification of low-attenuation peritoneal lesions with characteristic scalloping of visceral surfaces. Magnetic resonance imaging (MRI), less frequently reported in the literature for PMP, offered superior lesion characterization through high-resolution T2-weighted sequences, revealing hyperintense mucinous deposits. The combination of CT and MRI findings facilitated accurate diagnosis and staging, guiding surgical planning. Management involved cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC), which remains the standard approach for PMP, improving survival in selected patients. This case underscores the critical role of comprehensive radiological assessment, particularly the added value of MRI, in enhancing diagnostic accuracy and optimizing patient outcomes in rare presentations of PMP.

摘要

腹膜假黏液瘤(PMP)是一种罕见的临床病症,最常见于阑尾或卵巢黏液性肿瘤。本病例报告描述了一例极为罕见的起源于横结肠黏液腺癌的PMP,突出了独特的诊断和治疗挑战。多模态成像在诊断过程中发挥了关键作用,计算机断层扫描(CT)最初识别出具有特征性脏层表面扇贝样改变的低衰减腹膜病变。磁共振成像(MRI)在PMP的文献报道中较少见,通过高分辨率T2加权序列能提供更好的病变特征,显示出高信号的黏液性沉积物。CT和MRI结果的结合有助于准确诊断和分期,指导手术规划。治疗包括减瘤手术(CRS)联合腹腔内热灌注化疗(HIPEC),这仍是PMP的标准治疗方法,可提高部分患者的生存率。本病例强调了全面放射学评估的关键作用,尤其是MRI的附加价值,在提高罕见PMP病例诊断准确性和优化患者预后方面的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/4ba41d7d58dc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/c8668320241f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/c3b08aa9ec64/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/a371e21ba55e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/4ba41d7d58dc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/c8668320241f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/c3b08aa9ec64/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/a371e21ba55e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed17/12268026/4ba41d7d58dc/gr4.jpg

相似文献

1
Pseudomyxoma peritonei originating from transverse colon mucinous adenocarcinoma: CT and MRI insights from a rare case.源于横结肠黏液腺癌的腹膜假黏液瘤:1例罕见病例的CT和MRI影像分析
Radiol Case Rep. 2025 Jun 26;20(9):4604-4609. doi: 10.1016/j.radcr.2025.06.036. eCollection 2025 Sep.
2
Efficacy and safety in the use of intraperitoneal hyperthermia chemotherapy and peritoneal cytoreductive surgery for pseudomyxoma peritonei from appendiceal neoplasm: A systematic review.腹腔内热化疗联合腹膜减瘤术治疗阑尾肿瘤所致假性黏液瘤腹膜转移的疗效和安全性:一项系统评价。
Clinics (Sao Paulo). 2022 May 13;77:100039. doi: 10.1016/j.clinsp.2022.100039. eCollection 2022.
3
Diagnostic Pitfalls in Peritoneal Carcinomatosis: A Case of Pseudomyxoma Peritonei.腹膜癌病的诊断陷阱:一例腹膜假黏液瘤
Cureus. 2025 Jun 6;17(6):e85474. doi: 10.7759/cureus.85474. eCollection 2025 Jun.
4
Long-Term Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Pseudomyxoma Peritonei: A 22-Year Single Institution Experience.减瘤手术联合腹腔热灌注化疗(HIPEC)治疗腹膜假黏液瘤后的长期生存:一项单机构22年的经验
ANZ J Surg. 2025 Jun 20. doi: 10.1111/ans.70214.
5
The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review.人类假性黏液瘤腹膜和阑尾黏液性肿瘤的遗传特征和分子亚型:系统评价。
Cancer Metastasis Rev. 2023 Mar;42(1):335-359. doi: 10.1007/s10555-023-10088-0. Epub 2023 Feb 1.
6
Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis.接受细胞减灭术联合腹腔内化疗的假性黏液瘤腹膜病患之存活率提升:系统性回顾与荟萃分析。
J Surg Res. 2013 Jul;183(1):246-52. doi: 10.1016/j.jss.2012.12.040. Epub 2013 Jan 10.
7
Low-Grade Appendiceal Mucinous Neoplasm in a Patient With Ulcerative Colitis Detected on Routine Surveillance Colonoscopy: A Case Report and Review of Literature.在常规监测结肠镜检查中发现的溃疡性结肠炎患者的低级别阑尾黏液性肿瘤:一例报告并文献复习
Cureus. 2025 Jun 12;17(6):e85844. doi: 10.7759/cureus.85844. eCollection 2025 Jun.
8
National Guidelines for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Malignancies: A Worldwide Systematic Review and Recommendations of Strength Analysis.腹膜恶性肿瘤细胞减灭术和腹腔热灌注化疗(HIPEC)的国家指南:一项全球系统性综述及强度分析建议
Ann Surg Oncol. 2025 May 24. doi: 10.1245/s10434-025-17518-z.
9
Contrast-Enhanced Ultrasound in the diagnosis of Pseudomyxoma peritonei; a case report.
Med Ultrason. 2025 Sep 17;27(3):358-360. doi: 10.11152/mu-4528. Epub 2025 Jun 19.
10
Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei.用于治疗腹膜假黏液瘤的Sugarbaker手术的临床疗效及成本
Health Technol Assess. 2004 Feb;8(7):iii, 1-54. doi: 10.3310/hta8070.

本文引用的文献

1
Recurrence and metastasis of pseudomyxoma peritonei: A rare case report.腹膜假黏液瘤的复发与转移:1例罕见病例报告
Radiol Case Rep. 2024 May 6;19(8):2929-2933. doi: 10.1016/j.radcr.2024.04.034. eCollection 2024 Aug.
2
Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines.关于腹膜假黏液瘤的共识和争议:对已发表的共识声明和指南的综述。
Orphanet J Rare Dis. 2021 Feb 13;16(1):85. doi: 10.1186/s13023-021-01723-6.
3
Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review.
源于横结肠黏液腺癌的腹膜假黏液瘤:一例报告及文献复习
Gastroenterol Res Pract. 2020 Jul 3;2020:5826214. doi: 10.1155/2020/5826214. eCollection 2020.
4
Pseudomyxoma peritonei: visceral scalloping on CT is a predictor of recurrence after complete cytoreductive surgery.腹膜假黏液瘤:CT 上的内脏扇贝征是完全细胞减灭术后复发的预测因素。
Eur Radiol. 2020 Aug;30(8):4193-4200. doi: 10.1007/s00330-020-06756-2. Epub 2020 Mar 24.
5
Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.阑尾肿瘤和腹膜假黏液瘤:文献综述及 PSOGI/EURACAN 诊断和治疗临床实践指南。
Eur J Surg Oncol. 2021 Jan;47(1):11-35. doi: 10.1016/j.ejso.2020.02.012. Epub 2020 Feb 28.
6
Pseudomyxoma Peritonei: Case Report and Literature Review.腹膜假黏液瘤:病例报告及文献综述
J Gastrointest Cancer. 2019 Dec;50(4):1037-1042. doi: 10.1007/s12029-018-00192-8.
7
Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.晚期结直肠癌患者程序性死亡配体 1、p53 和 Ki-67 的预后价值。
Hum Pathol. 2018 Jan;71:20-29. doi: 10.1016/j.humpath.2017.07.014. Epub 2017 Aug 4.
8
Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms.黏液性阑尾肿瘤所致腹膜假黏液瘤患者术前CT和MRI对不可切除性的预测
Eur J Surg Oncol. 2016 Apr;42(4):558-66. doi: 10.1016/j.ejso.2016.01.005. Epub 2016 Jan 22.
9
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.腹膜假黏液瘤及相关阑尾肿瘤的分类与病理报告共识:国际腹膜表面肿瘤学组(PSOGI)改良德尔菲法的结果
Am J Surg Pathol. 2016 Jan;40(1):14-26. doi: 10.1097/PAS.0000000000000535.
10
The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).基于炎症的基线评分和血清肿瘤标志物在接受肿瘤细胞减灭术(CRS)和腹腔热灌注化疗(HIPEC)治疗的腹膜假黏液瘤患者风险分层中的作用。
Eur J Surg Oncol. 2015 Aug;41(8):1097-105. doi: 10.1016/j.ejso.2015.04.005. Epub 2015 May 16.